Dollars for Docs

How Industry Dollars Reach Your Doctors

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

KISHAN S PATEL
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.

KISHAN S PATEL

Listed Specialty: Neurology
6565 FANNIN ST, MGJ9-021, HOUSTON, TX, 77030-2703
Search this name in Dollars for Docs Archive →
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.

KISHAN PATEL,
Yearly Payment Breakdown:

2018 Payments At a Glance

45

payments

$884

payment total

12

companies paid this doctor

Payment Calendar in 2018

This doctor received a payment on days in 2018.

Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.

2018

Types of Payments in 2018

Category Payments Payment Value
Food and Beverage
 43 $845
Promotional Speaking/Other
 2 $39

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
HIZENTRA

drug

 $115
POMPE - DISEASE

drug

 $115
NUEDEXTA

drug

 $111
LUMIZYME

drug

 $101
GILENYA

drug

 $85
SOLITAIRE

device

 $82
AUBAGIO

drug

 $59
ACTIVASE

drug

 $51
BOTOX

drug

 $48
AMPYRA

drug

 $39
XARELTO

drug

 $39
PRIVIGEN

drug

 $25
FABRAZYME

drug

 $25
FABRY-DISEASE

drug

 $25
Payments with no listed product

N/A

 $21
WATCHMAN

device

 $21
AIMOVIG

drug

 $21
MS DISEASE STATE

drug

 $18
SOLIRIS

drug

 $17
INGREZZA

drug

 $16
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details in 2018

When How Much Related To What For From Third Party Payee
Jun 13, 2018 $82 SOLITAIRE Food and Beverage MEDTRONIC USA, INC.
Mar 15, 2018 $25 LUMIZYME POMPE - DISEASE Food and Beverage GENZYME CORPORATION
Nov 19, 2018 $25 PRIVIGEN Food and Beverage CSL BEHRING
Jun 13, 2018 $25 FABRAZYME LUMIZYME POMPE - DISEASE FABRY-DISEASE Food and Beverage GENZYME CORPORATION
Apr 17, 2018 $24 GILENYA Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Oct 30, 2018 $23 HIZENTRA Food and Beverage CSL BEHRING
Jun 11, 2018 $22 NUEDEXTA Food and Beverage AVANIR PHARMACEUTICALS, INC.
Feb 20, 2018 $21 No Listed Product Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Jun 27, 2018 $21 WATCHMAN Food and Beverage BOSTON SCIENTIFIC CORPORATION
Mar 20, 2018 $21 GILENYA Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Oct 3, 2018 $21 AIMOVIG Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Dec 5, 2018 $21 HIZENTRA Food and Beverage CSL BEHRING
Nov 13, 2018 $21 NUEDEXTA Food and Beverage AVANIR PHARMACEUTICALS, INC.
Apr 19, 2018 $21 HIZENTRA Food and Beverage CSL BEHRING
Jul 19, 2018 $21 HIZENTRA Food and Beverage CSL BEHRING
Oct 9, 2018 $20 NUEDEXTA Food and Beverage AVANIR PHARMACEUTICALS, INC.
Aug 1, 2018 $20 GILENYA Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Jun 26, 2018 $20 GILENYA Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Feb 6, 2018 $20 AMPYRA Promotional Speaking/Other ACORDA THERAPEUTICS, INC
Sep 4, 2018 $20 LUMIZYME POMPE - DISEASE Food and Beverage GENZYME CORPORATION
Nov 14, 2018 $19 AMPYRA Promotional Speaking/Other ACORDA THERAPEUTICS, INC
Aug 21, 2018 $19 NUEDEXTA Food and Beverage AVANIR PHARMACEUTICALS, INC.
Aug 31, 2018 $19 ACTIVASE Food and Beverage GENENTECH USA, INC.
May 1, 2018 $19 BOTOX Food and Beverage ALLERGAN INC.
Jun 20, 2018 $18 MS DISEASE STATE Food and Beverage GENZYME CORPORATION
Jul 17, 2018 $18 NUEDEXTA Food and Beverage AVANIR PHARMACEUTICALS, INC.
Aug 16, 2018 $18 HIZENTRA Food and Beverage CSL BEHRING
Dec 3, 2018 $17 SOLIRIS Food and Beverage ALEXION PHARMACEUTICALS, INC.
Oct 26, 2018 $17 ACTIVASE Food and Beverage GENENTECH USA, INC.
May 16, 2018 $17 AUBAGIO Food and Beverage GENZYME CORPORATION
Jul 11, 2018 $16 INGREZZA Food and Beverage NEUROCRINE BIOSCIENCES, INC.
Apr 9, 2018 $16 LUMIZYME POMPE - DISEASE Food and Beverage GENZYME CORPORATION
Oct 24, 2018 $16 AUBAGIO Food and Beverage GENZYME CORPORATION
Feb 21, 2018 $16 AUBAGIO Food and Beverage GENZYME CORPORATION
Aug 23, 2018 $15 LUMIZYME POMPE - DISEASE Food and Beverage GENZYME CORPORATION
May 8, 2018 $15 ACTIVASE Food and Beverage GENENTECH USA, INC.
Mar 8, 2018 $15 BOTOX Food and Beverage ALLERGAN INC.
Nov 15, 2018 $14 BOTOX Food and Beverage ALLERGAN INC.
Nov 7, 2018 $14 POMPE - DISEASE Food and Beverage GENZYME CORPORATION
Jul 27, 2018 $13 XARELTO Food and Beverage JANSSEN PHARMACEUTICALS, INC
Aug 13, 2018 $13 XARELTO Food and Beverage JANSSEN PHARMACEUTICALS, INC
Aug 20, 2018 $13 XARELTO Food and Beverage JANSSEN PHARMACEUTICALS, INC
Sep 13, 2018 $12 HIZENTRA Food and Beverage CSL BEHRING
Apr 2, 2018 $11 NUEDEXTA Food and Beverage AVANIR PHARMACEUTICALS, INC.
Aug 22, 2018 $11 AUBAGIO Food and Beverage GENZYME CORPORATION
See this doctor’s Open Payments page →

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.